David A. Siegel Vigil Neuroscience, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 20,100 shares of VIGL stock, worth $33,165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,100Holding current value
$33,165% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VIGL
# of Institutions
53Shares Held
27.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$9.63 Million2.45% of portfolio
-
Northpond Ventures, LLC4.21MShares$6.95 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$3.29 Million0.34% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$2.99 Million0.2% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.65MShares$2.72 Million1.03% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $46.6M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...